Explore the Global General Anesthesia Drugs Market — analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

General Anesthesia Drugs Market

Key Insight

Demand for general anesthesia drugs will increase through 2036, with propofol at 35.0% of the drug class segment in 2026, driven by surgical procedure volume growth and expanding surgical infrastructure. The market was valued at USD 5.20 billion in 2025 and is expected to be worth USD 7.12 billion by 2036.

May 06, 2026

Anurag Sharma

306 Pages

Cite this Report

General Anesthesia Drugs Market

https://www.futuremarketinsights.com/reports/general-anesthesia-drugs-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

Baxter International
Fresenius Kabi AG
Hikma Pharmaceuticals PLC
The Vanguard Group
Mylan N.V. (Viatris Inc.)

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

General Anesthesia Drugs Market

Key Players

Similar Industry Reports